You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
McKinsey
McKesson
Colorcon
Baxter

Last Updated: May 25, 2020

DrugPatentWatch Database Preview

Gonadotropin, chorionic - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for gonadotropin, chorionic

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Cairo UniversityPhase 2
Moustafa Mohammed AboueleaEarly Phase 1
Bagcilar Training and Research HospitalPhase 4

See all gonadotropin, chorionic clinical trials

Recent Litigation for gonadotropin, chorionic

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Uniloc 2017 LLC v. Paychex, Inc.2019-06-07
Amgen Inc. v. Accord Healthcare, Inc.2018-06-28
Par Pharmaceutical, Inc. v. Eagle Pharmaceuticals, Inc.2018-05-31

See all gonadotropin, chorionic litigation

PTAB Litigation
PetitionerDate
2013-07-29

See all gonadotropin, chorionic litigation

Patent Text Search: US Patents for gonadotropin, chorionic

These patents were identified by searching patent claims

Supplementary Protection Certificates for gonadotropin, chorionic

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
07C/027 Belgium   Start Trial PRODUCT NAME: PERFLUTREN; AUTHORISATION NUMBER AND DATE: EU/1/06/361/001 20060922
27/2007 Austria   Start Trial PRODUCT NAME: PERFLUTREN ENTHALTENDE LIPID-MIKROPARTIKEL
C0004 France   Start Trial PRODUCT NAME: HORMONE FOLLICULO-STIMULANTE COMPRENANT UNE EXTENSION CTP, NOTAMMENT LA CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE IN FRANCE: EU/1/09/609/001 DU 20100125; REGISTRATION NO/DATE AT EEC: EU/1/09/609/001 DU 20100125
C028/2001 Ireland   Start Trial SPC028/2001: 20031204, EXPIRES: 20160607
2010000006 Germany   Start Trial PRODUCT NAME: CORIFOLLITROPIN ALFA; REGISTRATION NO/DATE: EU/1/09/609/001-002 20100125
C0010 Belgium   Start Trial PRODUCT NAME: FOLLITROPINE ALPHA; NAT. REGISTRATION NO/DATE: EU1/95/001/001 19951020; FIRST REGISTRATION: FI 11529 19940815
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
McKinsey
Merck
Mallinckrodt
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.